IHS Chemical Week

Archives :: Chem Ideas

Displaying 201 - 212 of 965 stories.
November 19, 2013
DSM and JLL form $2-billion pharma services firm by merging DSM Pharmaceutical Products with Patheon DSM and JLL Partners (New York), a middle-market private equity firm, will create a...
November 15, 2013
This Week in CW: A few more companies reported earnings this week as the season comes to an end. K+S’ third-quarter revenues were down 11%, to €817.7 million, with potash...
November 14, 2013
Project cost engineers overseeing maintenance shutdowns have built some amazing Excel spreadsheets used to calculate hours and costs and create forecasts. But, spreadsheets are only as...
November 12, 2013
CPhI 2013: Bullish mood at Frankfurt CPhI, the largest annual trade fair for the global pharmaceutical and pharma ingredients industry and held recently at Frankfurt, attracted about...
November 8, 2013
This Week in CW: Earnings season is slowing down as fewer companies reported this week. In Europe, Arkema posted Ebitda of €233 million ($315 million) in third-quarter 2013, a...
November 5, 2013
Specialty ingredients business boosts Lonza’s third-quarter performance Lonza, in its business update announcement for the third quarter, says that its overall business...
November 1, 2013
This Week in CW: Several more companies reported earnings this week. In Asia, Tosoh reported a net profit of ¥14.1 billion ($144 million) in the fiscal first half, ended 30...
October 30, 2013
DuPont’s July 2013 announcement that it would explore strategic options for its $7-billion/year performance chemicals business unit, as part of its transformation to a “higher growth, less cyclical company,” is a bold, but necessary, strategic move by company leadership, according to new analysis by IHS Chemical. DuPont announced last week that it would spin off the company within 18 months. The move, IHS says, allows DuPont to refocus its resources on core businesses in agriculture and nutrition, as well as biobased and advanced materials, where DuPont has a carved a scientific niche, and businesses that offer both higher margin potential and a more consistent revenue stream....
October 30, 2013
As demand intensifies to reduce the use of carbon-based raw materials, companies are looking at how they can reduce consumption and find appropriate replacements.
...

October 29, 2013
American Capital to invest $391 million in the combination of Cambridge Major and AAIPharma Private equity firm American Capital (Bethesda, MD) says that it has committed $391 million...
October 25, 2013
This Week in CW: Earnings season is in full swing as companies continue to report varied results. BASF reported an 18.5% increase in third-quarter net income to €1.1 billion ($1.5...
October 21, 2013
AstraZeneca acquires ADC technology firm Spirogen AstraZeneca (London) says that its biologics R&D arm, MedImmune (Gaithersburg, MD), has acquired Spirogen (London), a privately...
Pages: « Previous  12 13 14 15 16 17 18 19 20 [21] 22 23 24 25 26 27 28 29 30 Next »




RSS Follow us on Twitter Join us on LinkedIn Like us on Facebook Youtube channel
contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa